NAD reviews Nutrex claim
This article was originally published in The Tan Sheet
Executive Summary
The claim that Vitrix Maximum Impact dietary supplement enables users to "have the best sex" of their lives is not mere puffery in the context it is used by Nutrex, but qualifies as an unsupported claim, says the National Advertising Division. While the phrase on its own could be puffery, the Council of Better Business Bureaus unit decides Feb. 2 that additional claims of testosterone boosting and sexual performance improvement render the claim unsupported by science. The Council for Responsible Nutrition challenged Oviedo, Fla.-based Nutrex's claim, arguing that scientific literature on the testosterone-stimulating qualities of the herb Tribulus terristris and other ingredients in Vitrix should not apply to the product. Nutrex says it has discontinued or modified several product claims as a result of the NAD decision, despite disagreeing with aspects of it
You may also be interested in...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.